Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12629304 | 0.79 | LMNA (0.41) | ALDH1A1LMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL12664570 | 0.79 | LMNA (0.41) | ALDH1A1LMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL24819656 | 0.79 | UGT2B7 (0.49) | UGT2B7MEN1KMT2ACYP1A2CYP2D6 | |
| SCHEMBL12706112 | 0.79 | LMNA (0.43) | ALDH1A1LMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL20193367 | 0.77 | UGT2B7 (0.58) | UGT2B7MEN1KMT2ACYP1A2CYP2D6 | |
| SCHEMBL14255152 | 0.77 | CA2 (0.44) | ALDH1A1LMNASMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL27283047 | 0.77 | LMNA (0.42) | ALDH1A1LMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL9194319 | 0.77 | AKR1C3 (0.53) | UGT2B7PKMALDH1A1LMNAL3MBTL1 | |
| SCHEMBL14566923 | 0.76 | AKR1C3 (0.49) | PKMALDH1A1GAAMEN1KMT2A | |
| SCHEMBL18052665 | 0.76 | TSHR (0.52) | ALDH1A1LMNASMN1; SMN2KMT2ACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8574608-B2 | Bactericidal silver surfactant delivery into coating and polymer compositions | Eastern Michigan Universtity (US) | 2013-11-05 | — | — | US | disclosed |
| US-20130259916-A1 | BACTERICIDAL SILVER SURFACTANT DELIVERY INTO COATING AND POLYMER COMPOSITIONS | EASTERN MICHIGAN UNIVERSITY (US) | 2013-10-03 | — | — | US | disclosed |
| US-8268338-B2 | Bactericidal silver surfactant delivery into coating and polymer compositions | EASTERN MICHIGAN UNIVERSITY (US) | 2012-09-18 | — | — | US | disclosed |
| US-20090060984-A1 | ANIONIC SURFACTANTS LETHAL TO GRAM-POSITIVE BACTERIA | EASTERN MICHIGAN UNIVERSITY | 2009-03-05 | — | — | US | disclosed |
| US-20090018188-A1 | BACTERICIDAL SILVER SURFACTANT DELIVERY INTO COATING AND POLYMER COMPOSITIONS | EASTERN MICHIGAN UNIVERSITY | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018188-A1 | BACTERICIDAL SILVER SURFACTANT DELIVERY INTO COATING AND POLYMER COMPOSITIONS | CAPG, CLTB, DSTN | UGT2B7 1570/4885PKM 4640/4885ALDH1A1 3875/4885 |
| US-20130259916-A1 | BACTERICIDAL SILVER SURFACTANT DELIVERY INTO COATING AND POLYMER COMPOSITIONS | CAPG, CLTB, DSTN | UGT2B7 1570/4885PKM 4640/4885ALDH1A1 3875/4885 |
| US-20090060984-A1 | ANIONIC SURFACTANTS LETHAL TO GRAM-POSITIVE BACTERIA | PHOSPHO1, DDOST, SGMS1 | UGT2B7 3467/4885PKM 4393/4885ALDH1A1 4759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.